This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion.

The solid progress of nanomedicine.

Celia C
;
Schmid R;
2020-01-01

Abstract

This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion.
2020
Inglese
ELETTRONICO
10
3
726
729
4
Cancer therapy; Clinical translation; Nanomedicine; Nanotechnology; Reproducibility
https://link.springer.com/article/10.1007/s13346-020-00743-2
13
info:eu-repo/semantics/article
262
Martins, Jp; das Neves, J; de la Fuente, M; Celia, C; Florindo, H; Günday-Türeli, N; Popat, A; Santos, Jl; Sousa, F; Schmid, R; Wolfram, J; Sarmento, ...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
open
File in questo prodotto:
File Dimensione Formato  
Martins2020_Article_TheSolidProgressOfNanomedicine.pdf

accesso aperto

Descrizione: Original Article
Tipologia: PDF editoriale
Dimensione 252.46 kB
Formato Adobe PDF
252.46 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11564/719063
Citazioni
  • ???jsp.display-item.citation.pmc??? 24
  • Scopus 99
  • ???jsp.display-item.citation.isi??? 85
social impact